EGFR and lung cancer: In this present work, we have highlighted an induced overexpressed SOX2‐OT level, where siRNAs knockdown of SOX2‐OT reduces total‐ and phosphorylated‐AKT protein levels in EGFR‐wild‐type, KRAS‐mutated A549 lung cancer cells.